Sylvamo (SLVM) director receives 3,876 RSUs for 2026-2027 board service

Rhea-AI Filing Summary

Sylvamo Corp director Christine S. Breves received a grant of 3,876 shares of common stock in the form of time-based restricted stock units. The grant was priced at $38.70 per share and increased her direct holdings to 19,076 shares.

The RSUs were awarded for service as a director for the 2026-2027 performance year. They will vest and settle one-for-one in common stock upon the earlier of May 13, 2027, or the next annual shareowners meeting, making this a compensation-related, not open-market, acquisition.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Breves Christine S

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,876	$38.70	$150K

Holdings After Transaction: Common Stock — 19,076 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 3,876 shares Grant reference price: $38.70 per share Shares held after grant: 19,076 shares +1 more

4 metrics

RSU grant size 3,876 shares Time-based restricted stock units granted for 2026-2027 performance year

Grant reference price $38.70 per share Price per share used for the RSU grant

Shares held after grant 19,076 shares Total direct holdings following the RSU award

Latest vesting date May 13, 2027 RSUs vest on the earlier of this date or the next annual meeting

Key Terms

restricted stock units, time-based, performance year, annual shareowners meeting

4 terms

restricted stock units financial

"The reported securities represent time-based restricted stock units ("RSUs") that were granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

time-based financial

"The reported securities represent time-based restricted stock units ("RSUs") that were granted"

performance year financial

"granted to the reporting person for service as a director for the 2026-2027 performance year"

annual shareowners meeting financial

"upon the earlier of May 13, 2027, or the next annual shareowners meeting"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breves Christine S

(Last) (First) (Middle)

6077 PRIMACY PARKWAY

(Street)

MEMPHIS TENNESSEE 38119

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sylvamo Corp [ SLVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		3,876	A(1)	$38.7	19,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent time-based restricted stock units ("RSUs") that were granted to the reporting person for service as a director for the 2026-2027 performance year. The RSUs will vest and settle one-for-one in common stock upon the earlier of May 13, 2027, or the next annual shareowners meeting.

Remarks:

	/s/ Erin Raccah, attorney in fact for Christine S. Breves	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Sylvamo (SLVM) report for Christine S. Breves?

Sylvamo reported that director Christine S. Breves received 3,876 time-based restricted stock units, representing common stock at $38.70 per share. This is a compensation-related grant for board service, not an open-market stock purchase or sale.

How many Sylvamo (SLVM) shares does Christine S. Breves hold after this Form 4?

After the restricted stock unit grant, Christine S. Breves directly holds 19,076 shares of Sylvamo common stock. This total includes the 3,876 RSUs reported in the Form 4, which will settle into shares once the vesting conditions are met.

What are the vesting terms of the Sylvamo (SLVM) RSUs granted to Christine S. Breves?

The 3,876 time-based restricted stock units will vest and settle one-for-one in Sylvamo common stock upon the earlier of May 13, 2027, or the next annual shareowners meeting. These terms tie the award to her continued service as a director.

Was the Sylvamo (SLVM) Form 4 transaction a market buy or sell?

The Form 4 reflects a grant or award acquisition, not a market buy or sell. Christine S. Breves received 3,876 restricted stock units as director compensation, so no open-market trading decision or price negotiation is involved in this transaction.

Why did Sylvamo (SLVM) grant 3,876 RSUs to director Christine S. Breves?

The 3,876 restricted stock units were granted as compensation for service as a director during the 2026-2027 performance year. This equity award aligns her interests with shareholders by delivering value in Sylvamo common stock subject to vesting conditions tied to her board service.